DUBLIN--(BUSINESS WIRE)--The "Metagenomics Market to 2027 - Global Analysis and Forecasts by Product, Application and Geography" report has been added to ResearchAndMarkets.com's offering.
The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027.
Driving factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics. Whereas, the trend of the extensive set of molecular-based approaches positive impact on the growth of the market in the coming years. However, high capital costs of metagenomics is anticipated to restrain the market growth.
The current trend of the molecular-based approaches has enabled the field of the metagenomics to study the uncultured microorganisms. The metagenomics has also helped in the huge way for the clinical diagnostics and the clinical diagnostics is the current trend going on cross the world. Also the extensive research is been going-on currently for the environmental sectors. Also the metagenomics have potential to discover products for the biotechnology, agriculture biotechnology, food technology and others.
The potential of the metagenomics in the pharmaceuticals owe to the large hopes for growth opportunities for the market players. Also the novel innovations from the market players are likely to discover the solutions for the chronic infectious diseases.
The initial cost of the primary set up for the metagenomics is very high, however, the technological advancement and the efforts by the market leader such as Illumina Inc., Pacific Bioscience of California Inc., among the others are likely to meet this challenge. These market players are aggressively working to provide cost effective solutions for the metagenomics studies. The healthcare industry is likely to experience the positive outcomes in the coming future.
Global metagenomics market, based on the application was segmented into clinical diagnostics, drug discovery, and other applications. Clinical Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the forecast period. The metagenomics offers prodigious potential for the identification of uncultured microorganism that can be used to detect and diagnose infectious diseases and the genetic properties of the microorganism. Therefore, the segment held the largest market share of 47.9% for the application segment in the metagenomics market and is likely to dominate the market in coming forecast period.
Key Topics Covered
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
2. Global Metagenomics Market - Key Takeaways
3. Global Metagenomics Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Global Metagenomics Market - by Product
3.2.2 Global Metagenomics Market - by Application
3.2.3 Global Metagenomics Market - by Geography
3.3 Pest Analysis
3.3.1 North America - Pest Analysis
3.3.2 Europe- Pest Analysis
3.3.3 Asia Pacific- Pest Analysis
3.3.4 Middle East and Africa- Pest Analysis
3.3.5 South and Central America - Pest Analysis
4. Global Metagenomics Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Venture Capital Investments
4.1.2 Advantages of Metagenomics In Biotechnology
4.1.3 Industrial Applications of Metagenomics
4.2 Key Market Restraints
4.2.1 High Capital Costs of Metagenomics
4.3 Key Market Opportunities
4.3.1 Usage of Metagenomics For Precision Medicine
4.3.2 Emerging Nations
4.4 Key Market Trends
4.4.1 Extensive Set of Molecular-Based Approaches
4.5 Impact Analysis
5. Metagenomics Market - Global Analysis
5.1 Global Metagenomics Market Revenue Forecasts and Analysis
5.2 Global Metagenomics Market, by Geography - Forecasts and Analysis
5.3 Market Positioning
5.4 Performance of Key Players
5.4.1 Illumina, Inc.
5.4.2 Qiagen
5.5 Expert Opinions
6. Global Metagenomics Market Analysis - by Product
6.1 Overview
6.2 Global Metagenomics Market, by Product, 2018 & 2027 (%)
6.3 Instruments & Software Market
6.3.1 Overview
6.3.2 Global Instruments & Software Market Revenue and Forecasts To 2027 (US$ Mn)
6.4 Consumables Market
6.4.1 Overview
6.4.2 Global Consumables Market Revenue and Forecasts To 2027 (US$ Mn)
7. Global Metagenomics Market Analysis - by Application
7.1 Overview
7.2 Global Metagenomics Market, by Application, 2018 & 2027 (%)
7.3 Clinical Diagnostic Market
7.3.1 Overview
7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts To 2027 (US$ Mn)
7.4 Drug Discovery Metagenomics Market
7.4.1 Overview
7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
7.5 Others Market
7.5.1 Overview
7.5.2 Global Others Market Revenue and Forecasts To 2027 (US$ Mn)
8. North America Metagenomics Market Revenue and Forecasts To 2027
9. Europe Metagenomics Market Revenue and Forecasts To 2027
10. Asia Pacific Metagenomics Market Revenue and Forecasts To 2027
11. Middle East and Africa Metagenomics Market Revenue and Forecasts To 2027
12. South and Central America Metagenomics Market Revenue and Forecasts To 2027
13. Metagenomics Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies In the Metagenomics Market, 2015-2018
13.3 Organic Developments
13.4 Organic Growth Strategies In the Metagenomics Market, 2015-2018
13.5 Product Launch
13.6 Product Approval
13.7 Expansion & Others
13.8 Inorganic Developments
13.9 Inorganic Growth Strategies In the Metagenomics Market, 2015-2018
13.10 Acquisitions
13.11 Agreements
13.12 Partnership & Collaboration
14. Metagenomics Market - Key Company Profiles
14.1 Merck KGaA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc.
14.3 Agilent Technologies Inc.
14.4 Qiagen
14.5 Bio-Rad Laboratories Inc.
14.6 Perkin Elmer Inc.
14.7 Illumina Inc.
14.8 F. Hoffmann-La Roche Ltd.
14.9 Oxford Nanopore Technologies Ltd.
14.10 Pacific Bioscience of California Inc.
For more information about this report visit https://www.researchandmarkets.com/r/xsldo1
